|
RNF115 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.334790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.051400E-01 |
| Normal-vs-Stage2 |
8.355600E-03 |
| Normal-vs-Stage3 |
1.298370E-01 |
| Normal-vs-Stage4 |
5.656200E-01 |
| Stage1-vs-Stage2 |
4.277500E-02 |
| Stage1-vs-Stage3 |
4.467200E-01 |
| Stage1-vs-Stage4 |
9.045200E-01 |
| Stage2-vs-Stage3 |
1.693380E-01 |
| Stage2-vs-Stage4 |
9.057700E-02 |
| Stage3-vs-Stage4 |
5.288400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.020000E-01 |
| Normal-vs-AfricanAmerican |
3.674600E-01 |
| Normal-vs-Asian |
3.588800E-01 |
| Caucasian-vs-AfricanAmerican |
1.258170E-01 |
| Caucasian-vs-Asian |
9.483600E-01 |
| AfricanAmerican-vs-Asian |
1.620570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.764020E-01 |
| Normal-vs-Female |
1.617400E-01 |
| Male-vs-Female |
8.200200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.714600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.614200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.157810E-01 |
| Normal-vs-Age(81-100Yrs) |
5.484300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.139230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.891190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.762100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.541600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.181000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.452400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.017400E-01 |
| Classical-VS-Follicular |
6.68490000022004E-07 |
| Classical-VS-Other |
2.353400E-01 |
| Classical-VS-Normal |
9.580600E-01 |
| Tall-VS-Follicular |
1.151600E-02 |
| Tall-VS-Other |
3.865400E-01 |
| Tall-VS-Normal |
3.106600E-01 |
| Follicular-VS-Other |
6.653800E-01 |
| Follicular-VS-Normal |
1.222170E-04 |
| Other-VS-Normal |
1.576620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.617600E-03 |
| Normal-vs-N1 |
4.347800E-01 |
| N0-vs-N1 |
1.992560E-01 |
|
|
